Cue Biopharma (CUE) initiated with Outperform rating and $13 price target at Baird.
DENTSPLY SIRONA (XRAY +0.4%) initiated with Neural rating and $57 price target at Evercore ISI.
Neon Therapeutics (NTGN) initiated with Outperform rating and $15 price target at Baird.
Celsion (CLSN -1.7%) initiated with Buy rating and $9 price target at Brookline Capital.
West Pharmaceutical Services (WST +0.8%) upgraded to Neutral with a $135 price target at BofA Merrill Lynch.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.